Showing 1 - 20 results of 5,265 for search '(( design based decrease ) OR ( a ((marker decrease) OR (marked decrease)) ))', query time: 0.54s Refine Results
  1. 1
  2. 2

    Relationship between the Gender Representation Disparity Index (GRDI) and average explicit sex markers in film criticism, illustrating a decrease in markers as the GRDI moves toward a female-dominated cast. by Jad Doughman (20636304)

    Published 2025
    “…<p>Relationship between the Gender Representation Disparity Index (GRDI) and average explicit sex markers in film criticism, illustrating a decrease in markers as the GRDI moves toward a female-dominated cast.…”
  3. 3
  4. 4
  5. 5

    Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
  6. 6

    Design of a Magnetic Nanoplatform Based on CD26 Targeting and HSP90 Inhibition for Apoptosis and Ferroptosis-Mediated Elimination of Senescent Cells by Maciej Wnuk (825978)

    Published 2024
    “…MNP@CD26@17D-mediated ferroptosis might be executed by ferritinophagy as judged by elevated levels of the ferritinophagy marker NCOA4 and a decreased pool of ferritin. As 24 h treatment with MNP@CD26@17D did not induce hemolysis in human erythrocytes <i>in vitro</i>, this newly designed nanoplatform could be considered as an optimal multifunctional tool to target and eliminate senescent cells of skin origin, overcoming their apoptosis resistance.…”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Orthogonal experimental design. by Yining Wang (432154)

    Published 2025
    “…Fatigue test results reveal that the ZM modifier markedly extends fatigue life, with a maximum increase of 128.9%, and reduces fatigue sensitivity to the stress ratio. …”
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20